is retatrutide prescription only 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗿𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲—𝗮𝗻𝗱 𝘄𝗵𝘆 𝗮𝗿𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝘀𝘁𝘂𝗱𝘆𝗶𝗻𝗴 𝗶𝘁? an investigational medication designed to act on three hormone pathways: GLP-1, GIP, and glucagon. Clinical research is exploring how Retatrutide Dosage Guide | Trial-Based

It may help them determine the diagnosis and appropriate treatment.

Summary: Retatrutide is a synthetic peptide medicine engineered to simultaneously activate GLP-1, GIP, and glucagon receptors, making it a triple receptor agonist under clinical investigation for obesity treatment

The placebo groups were administered water alone using the same schedule as for the liraglutide treatment groups

It underscores the necessity of improved futures for the obese

Reported Gastrointestinal Side Effects in Clinical Trials Phase 2 trial data show nausea, vomiting, diarrhoea, constipation, and upper abdominal pain are the most frequently reported gastrointestinal side effects, with incidence increasing at higher doses and most events being mild to moderate